End-of-Life Care Advocacy: Advance Directives and Patient Wishes

Advance directives and end-of-life planning occupy a critical intersection of medical ethics, federal and state law, and patient autonomy. This page covers the definition and legal structure of advance directives, the mechanisms through which they operate within clinical settings, the regulatory frameworks established by agencies such as the Centers for Medicare & Medicaid Services (CMS) and mandated under the Patient Self Determination Act of 1990, and the common points of failure that prevent documented wishes from being honored. The content is organized as a reference for patients, family members, healthcare professionals, and advocates working within the US system.

• Definition and Scope
• Core Mechanics or Structure
• Causal Relationships or Drivers
• Classification Boundaries
• Tradeoffs and Tensions
• Common Misconceptions
• Checklist or Steps (Non-Advisory)
• Reference Table or Matrix
• References

Definition and Scope

An advance directive is a legally recognized document — or a set of documents — through which a competent adult specifies medical treatment preferences and/or designates a surrogate decision-maker, to take effect in circumstances where that individual can no longer communicate decisions. The scope of advance directives under US law encompasses both instructional directives (statements about which treatments to pursue or forgo) and proxy directives (designations of another person to make decisions on the patient's behalf).

The Patient Self Determination Act (PSDA) of 1990, codified at 42 U.S.C. §§ 1395cc(f) and 1396a(w), requires all Medicare- and Medicaid-participating providers — including hospitals, skilled nursing facilities, home health agencies, hospice programs, and prepaid health organizations — to inform adult patients of their right to execute advance directives and to document whether a directive exists in the patient's medical record. Noncompliance with PSDA requirements constitutes a condition-of-participation violation subject to CMS enforcement.

The advance directive framework intersects directly with patient rights and responsibilities as defined under The Joint Commission (TJC) standards, specifically the Rights and Responsibilities of the Individual (RI) chapter, which requires accredited organizations to honor documented patient wishes including the right to refuse treatment.

Scope extends nationally but execution requirements vary by state. All 50 states and the District of Columbia have enacted statutes governing advance directives, though the specific forms, witness requirements, notarization mandates, and scope of recognized documents differ. The Uniform Health-Care Decisions Act (UHCDA), promulgated by the Uniform Law Commission, represents a model framework that approximately 10 states have adopted in some form.

Core Mechanics or Structure

Advance directives function through a two-stage mechanism: creation and activation. During the creation stage, a competent adult executes a document (or multiple documents) according to state-specific formalities. During the activation stage, a treating clinical team determines that the patient lacks decision-making capacity, at which point the directive governs treatment decisions or the designated healthcare proxy assumes authority.

The two primary structural instruments are:

Living Will (Instructional Directive): Specifies treatment preferences for defined medical conditions, typically terminal illness, permanent unconsciousness, or end-stage conditions. Common provisions address mechanical ventilation, artificial nutrition and hydration, resuscitation, dialysis, and palliative care intensity.

Durable Power of Attorney for Healthcare (DPAHC) / Healthcare Proxy: Designates a healthcare agent — sometimes called a proxy — to make medical decisions consistent with the patient's known values when the patient cannot do so. The term "durable" distinguishes this instrument from a general power of attorney, which lapses upon incapacity. The healthcare proxy and power of attorney framework operates under state-level enabling statutes that specify who may serve as agent and what authority that agent holds.

A third category, the Physician Orders for Life-Sustaining Treatment (POLST) paradigm, translates advance directive preferences into immediately actionable medical orders. POLST forms — known as MOLST (Medical Orders for Life-Sustaining Treatment) or MOST (Medical Orders for Scope of Treatment) in some states — are signed by a licensed clinician and accompany a patient across care settings. The National POLST organization maintains state-specific form libraries and endorsement criteria.

Clinical operationalization requires that treating teams locate and review the directive before invoking it, verify the patient's current capacity status (typically through formal capacity assessment under standards set by the American Bar Association's Health Care Decision-Making Resource Guide), and apply the document's provisions to the presenting clinical circumstances.

Causal Relationships or Drivers

Three structural drivers explain why advance directives are executed and why they fail to be honored at point of care.

Driver 1 — Incapacity at crisis: The primary trigger for advance directive use is sudden or progressive loss of decision-making capacity. Stroke, advanced dementia, traumatic injury, and septic shock are the most common conditions precipitating the need to rely on a directive. A 2014 systematic review published in Health Affairs found that 26.3% of adults require end-of-life decision-making, and of those, approximately 67% lacked capacity at the time decisions were required (Silveira et al., Health Affairs, 2014).

Driver 2 — Regulatory mandate: The PSDA mandate and TJC accreditation standards create institutional pressure to document directive status. CMS Conditions of Participation at 42 CFR § 489.102 require that patients be provided written information about advance directives at the time of admission.

Driver 3 — Communication failure: The most operationally significant driver of directive non-adherence is failure to transmit the document across care transitions. A directive stored only at home, or only in one hospital's electronic health record (EHR), may be unavailable in an emergency department or skilled nursing facility. As noted in research published by the Agency for Healthcare Research and Quality (AHRQ), fragmented documentation remains the leading proximate cause of treatment contrary to patient wishes in acute settings. The transitional care advocacy domain addresses this communication gap directly.

Classification Boundaries

Advance directives are distinguished from related instruments along three axes:

Instructional vs. Proxy: A living will is purely instructional; a DPAHC is purely designative. Most state forms combine both functions in a single document, but the legal effect of each component is distinct.

Advisory vs. Binding Medical Order: A living will is an advisory document that clinicians must consider and generally follow, subject to conscience objections with transfer obligations. A POLST/MOLST is a physician order with the same binding clinical authority as any other medical order in the patient's chart.

Advance Directive vs. Do-Not-Resuscitate (DNR): A DNR order is a specific clinical order, typically limited to cardiopulmonary resuscitation decisions. It does not address the full range of life-sustaining treatments and is not synonymous with an advance directive. A patient may have an advance directive without a DNR order, or a DNR without any broader advance directive.

State-Specific vs. Portable: Standard state forms are executed under one state's statute. Portability across state lines is addressed inconsistently; some states have enacted statutory reciprocity provisions, but this is not uniform across all jurisdictions. The advance directives and living wills reference page covers state-level form variations in greater detail.

Tradeoffs and Tensions

Specificity vs. Flexibility: Highly specific instructional directives reduce surrogate discretion but may not anticipate every clinical scenario. A directive that specifies "no mechanical ventilation" written during a period of chronic illness may conflict with a reversible acute respiratory event. Overly broad directives leave surrogate decision-makers with insufficient guidance.

Patient Autonomy vs. Institutional Conscience: The Emergency Medical Treatment and Labor Act (EMTALA) requires stabilizing treatment irrespective of advance directives in emergency settings, creating a structural tension between documented patient wishes and legal stabilization obligations. Separately, TJC and CMS permit providers to invoke institutional conscience objections but require transfer to a willing provider, a process that introduces delay in time-sensitive situations.

Surrogate Authority vs. Clinical Judgment: Healthcare proxies are empowered to make decisions consistent with the patient's values, but they do not override treating clinicians' professional obligations. Disputes between surrogates and clinical teams represent one of the most common triggers for hospital ethics committee consultations, as documented in patient advocacy explained contexts.

Documentation Portability vs. Privacy Protections: Broad sharing of advance directives across systems improves access at point of care but implicates HIPAA privacy protections. The HHS Office for Civil Rights HIPAA guidance addresses permissible sharing, but EHR interoperability gaps persist as a practical barrier.

Common Misconceptions

Misconception: An advance directive takes effect immediately upon signing.
Correction: An advance directive activates only when a patient is determined to lack decision-making capacity and (in the case of instructional directives) when the clinical condition meets the directive's specified trigger conditions. A signed document has no effect on a patient who retains capacity.

Misconception: A healthcare proxy can override any medical recommendation.
Correction: A healthcare proxy's authority extends to decisions consistent with the patient's expressed or inferred values and with available treatment options. Surrogates cannot demand clinically futile interventions or treatments outside the standard of care, as established under state law and institutional policy.

Misconception: A verbal statement of wishes is sufficient.
Correction: Verbal statements carry moral weight but lack the legal enforceability of executed written directives. In emergency settings, clinical teams cannot verify verbal statements and will default to life-sustaining treatment absent documentation.

Misconception: Advance directives are only for elderly or terminally ill patients.
Correction: Sudden incapacity can affect adults of any age. The PSDA applies to all adult patients admitted to covered facilities, and informed consent patient guide frameworks treat advance care planning as relevant throughout adult life.

Misconception: A POLST replaces an advance directive.
Correction: POLST is a complement to, not a replacement for, an advance directive. POLST translates the patient's documented or expressed wishes into immediate clinical orders but does not designate a proxy or address the full scope of future treatment decisions.

Checklist or Steps (Non-Advisory)

The following sequence reflects the process structure of advance directive execution and deployment as documented in CMS, TJC, and PSDA guidance. This is a reference framework, not individualized guidance.

1. Confirm state-specific form requirements — Identify the applicable state statute governing advance directives (living will, DPAHC, or combined form). The National Hospice and Palliative Care Organization (NHPCO) maintains a state-by-state form directory.

2. Complete the instructional component — Specify treatment preferences for defined clinical scenarios: terminal condition, permanent unconsciousness, and end-stage condition are the three categories addressed in most state forms.

3. Designate and confirm a healthcare proxy — Identify a primary agent and, where permitted by state law, an alternate agent. Confirm the designated individual understands the role and has access to the document.

4. Execute according to statutory formalities — Most states require either two disinterested witnesses or notarization, or both. Witness disqualification rules commonly exclude the designated proxy, heirs, and treating clinicians.

5. Distribute copies to all treating clinicians and facilities — Provide copies to the primary care provider, any specialists, the designated proxy, and any facility where care may be received. Store an accessible copy at home.

6. Request placement in the medical record — Confirm with each treating facility that the directive is scanned into the EHR and flagged in the record per PSDA and CMS Conditions of Participation requirements.

7. Consider POLST conversion — For patients with serious illness or advanced age, discuss with a treating clinician whether POLST or an equivalent state form is appropriate to convert directive preferences into active medical orders.

8. Review and update upon material change — Advance directives do not expire under most state statutes, but major health changes, changes in proxy availability, or changes in treatment preferences warrant review and re-execution.

Reference Table or Matrix

References

• Patient Self Determination Act of 1990, 42 U.S.C. §§ 1395cc(f) and 1396a(w)
• CMS Conditions of Participation — Advance Directives, 42 CFR § 489.102
• Centers for Medicare & Medicaid Services (CMS)
• The Joint Commission — Rights and Responsibilities of the Individual (RI) Standards
• National POLST — State Forms and Endorsement Criteria
• Uniform Law Commission — Uniform Health-Care Decisions Act
• National Hospice and Palliative Care Organization (NHPCO) — Advance Care Planning
• Agency for Healthcare Research and Quality (AHRQ)
• HHS Office for Civil Rights — HIPAA for Professionals
• American Bar Association — Health Care Decision-Making Resource Guide
• Silveira MJ et al., "Advance Directives and Outcomes of Surrogate Decision Making Before Death," Health Affairs, 2014